|Day Lo||-||Day Hi||-|
This ETF offers targeted exposure to health care services companies, a narrow slice of the U.S. economy that includes health care service providers, managed health care firms, health care facilities, and health care distributors. The health care sector may be appealing to investors looking to add stability to their portfolio, and this corner of the market is also capable of delivering solid distribution yields to investors. Given the relatively narrow focus, this fund probably is of little use to investors building a long-term, buy-and-hold portfolio; it will be more useful to those looking to establish a tactical tilt within their portfolios. There are a couple aspects of XHS that make this product noteworthy and unique from competing funds. First, the underlying index is equal weighted, a feature that results in a well balanced portfolio. That should be appealing to investors for a number of reasons, including the potential to avoid market cap weighting methodologies that some believe contain potential drawbacks to long-term performance. There are a number of broad-based funds in the Health & Biotech ETFdb Category that offer similar exposure to this corner of the market. For investors looking to achieve targeted exposure to health care services stocks, XHS is an efficient way to tap into this corner of the market.
The adjacent table gives investors an individual Realtime Rating for XHS on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.View the Category Report
The following tables and charts contain in-depth metrics for this ETF and compare it to similar peer ETFs within its ETFdb.com Category.
This section compares how balanced and deep this ETF is relative to the peer group ETFdb.com Category.
This ETF is not currently available for commission free trading on any platforms.
There are 6 other ETFs in the Health & Biotech Equities ETFdb.com Category that are also eligible for commission free trading:
This section shows how this ETF has performed relative to its peer group ETFdb.com Category.
This section compares the fund flows of this ETF to peers in the same ETFdb.com Category.
The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.
The following chart also includes the option to compare the performance of XHS relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.
This section shows how the volatility of this ETF compares to the peer group ETFdb.com Category.
Source: LSEG Information Services (US), Inc. (“LSEG”) © LSEG 2016. All rights in the XTF data, ratings and / or underlying data contained in this communication (“the XTF information”) vest in LSEG and/or its licensors. Neither LSEG nor its licensors accept any liability arising out of the use of, reliance on or any errors or omissions in the XTF information. No further distribution of the XTF information is permitted without LSEG’s express written consent. LSEG does not promote, sponsor or endorse the content of this communication.